Sinopharm’s vaccine is in Phase III trials with 15,000 subjects and two vaccine strains in the United Arab Emirates, Reuters reported last month. Last Thursday the Chinese researchers published a paper in the Journal of the American Medical Association saying the shot cause no serious side effects and did trigger antibody-based immune responses in earlier trials, Reuters reported.
Chinese drugmaker says coronavirus vaccine to be ready by year’s end, cost less than $150 for two shots
Prepare Now Before its too Late
Discover where products are available & compare prices
